Mariana Brutschin Pereira1,2, Luciana Rodrigues Carvalho Barros3, Paula A Bracco4, Alvaro Vigo5,4, Mariana Boroni6, Martín Hernán Bonamino3,7, Guido Lenz1,2. 1. Department of Biophysics and Center of Biotechnology, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil. 2. Center of Biotechnology, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil. 3. Molecular Carcinogenesis Program, Research Coordination, National Cancer Institute (INCA), Rio de Janeiro, RJ, Brazil. 4. Graduate Program in Epidemiology, Federal University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil. 5. Departament of Statistics, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil. 6. Bioinformatics and Computacional Biology Lab, National Cancer Institute (INCA), Rio de Janeiro, RJ, Brazil. 7. FIOCRUZ - Oswaldo Cruz Foundation Institute, Rio de Janeiro, RJ, Brazil.
Abstract
Introduction: Several cell populations from the peripheral immune system interact to create a complex immunologic status during glioblastoma growth and response to therapy. The aim of this study was to integrate the impact of different immune cell populations present in glioblastoma tumor microenvironment on overall survival. Methodology: Gene expression and clinical data were generated by The Cancer Genome Atlas and previously reported meta-signatures representing cells of the immune system were used. The relationship between meta-signatures was evaluated through Pearson's correlation analyses. Survival analyses were performed through Kaplan-Meier plots and Cox regression model. Results and discussion: Meta-signatures corresponding to infiltrating immune cells with immunosuppressive roles, such as macrophages, NK and NK T cells, MDSCs and Tregs, correlated with poorer patient prognosis. Meta-signatures related to CD8+ T cells predicted improved survival only in patients with low immunosuppressive meta-signatures. By clustering the meta-signatures we found that the cluster containing high meta-signatures of macrophages, MDSCs and Tregs demonstrated the worst prognosis. Conclusion: Integrating the information provided by transcriptional signatures of immunological aspects is fundamental in understanding the impact of the immune system on patient survival. We found a predictive impact on survival with positive role for CD8 and negative roles for macrophages, MDSC, Tregs, NK and NK-T in glioblastoma patients. Understanding these regulatory and stimulatory factors of patients' immune system is essential to delineate an effective strategy to increase the anti-tumor immune response and to generate potential clinical benefits.
Introduction: Several cell populations from the peripheral immune system interact to create a complex immunologic status during glioblastoma growth and response to therapy. The aim of this study was to integrate the impact of different immune cell populations present in glioblastoma tumor microenvironment on overall survival. Methodology: Gene expression and clinical data were generated by The Cancer Genome Atlas and previously reported meta-signatures representing cells of the immune system were used. The relationship between meta-signatures was evaluated through Pearson's correlation analyses. Survival analyses were performed through Kaplan-Meier plots and Cox regression model. Results and discussion: Meta-signatures corresponding to infiltrating immune cells with immunosuppressive roles, such as macrophages, NK and NK T cells, MDSCs and Tregs, correlated with poorer patient prognosis. Meta-signatures related to CD8+ T cells predicted improved survival only in patients with low immunosuppressive meta-signatures. By clustering the meta-signatures we found that the cluster containing high meta-signatures of macrophages, MDSCs and Tregs demonstrated the worst prognosis. Conclusion: Integrating the information provided by transcriptional signatures of immunological aspects is fundamental in understanding the impact of the immune system on patient survival. We found a predictive impact on survival with positive role for CD8 and negative roles for macrophages, MDSC, Tregs, NK and NK-T in glioblastomapatients. Understanding these regulatory and stimulatory factors of patients' immune system is essential to delineate an effective strategy to increase the anti-tumor immune response and to generate potential clinical benefits.
Authors: Michael Prosniak; Larry A Harshyne; David W Andrews; Lawrence C Kenyon; Kamila Bedelbaeva; Tatiyana V Apanasovich; Ellen Heber-Katz; Mark T Curtis; Paolo Cotzia; D Craig Hooper Journal: Clin Cancer Res Date: 2013-06-05 Impact factor: 12.531
Authors: Joseph L Wiemels; John K Wiencke; Jennette D Sison; Rei Miike; Alex McMillan; Margaret Wrensch Journal: Int J Cancer Date: 2002-04-01 Impact factor: 7.396
Authors: C Marcela Diaz-Montero; Mohamed Labib Salem; Michael I Nishimura; Elizabeth Garrett-Mayer; David J Cole; Alberto J Montero Journal: Cancer Immunol Immunother Date: 2008-04-30 Impact factor: 6.968
Authors: Konrad Gabrusiewicz; Mohammad B Hossain; Nahir Cortes-Santiago; Xuejun Fan; Bozena Kaminska; Frank C Marini; Juan Fueyo; Candelaria Gomez-Manzano Journal: Neoplasia Date: 2015-04 Impact factor: 5.715
Authors: Cristina Barca; Claudia Foray; Bastian Zinnhardt; Alexandra Winkeler; Ulrich Herrlinger; Oliver M Grauer; Andreas H Jacobs Journal: Cancers (Basel) Date: 2022-06-27 Impact factor: 6.575
Authors: Yaoqing Shen; Cameron J Grisdale; Sumaiya A Islam; Pinaki Bose; Jake Lever; Eric Y Zhao; Natalie Grinshtein; Yussanne Ma; Andrew J Mungall; Richard A Moore; Xueqing Lun; Donna L Senger; Stephen M Robbins; Alice Yijun Wang; Julia L MacIsaac; Michael S Kobor; H Artee Luchman; Samuel Weiss; Jennifer A Chan; Michael D Blough; David R Kaplan; J Gregory Cairncross; Marco A Marra; Steven J M Jones Journal: Proc Natl Acad Sci U S A Date: 2019-08-30 Impact factor: 11.205
Authors: Jun Wei; Peiwen Chen; Pravesh Gupta; Martina Ott; Daniel Zamler; Cynthia Kassab; Krishna P Bhat; Michael A Curran; John F de Groot; Amy B Heimberger Journal: Neuro Oncol Date: 2020-02-20 Impact factor: 12.300
Authors: Yang Xu; Renpeng Li; Xiaoxia Li; Naijun Dong; Di Wu; Lin Hou; Kan Yin; Chunhua Zhao Journal: Front Oncol Date: 2020-10-19 Impact factor: 6.244
Authors: Astrid De Boeck; Bo Young Ahn; Charlotte D'Mello; Xueqing Lun; Shyam V Menon; Mana M Alshehri; Frank Szulzewsky; Yaoqing Shen; Lubaba Khan; Ngoc Ha Dang; Elliott Reichardt; Kimberly-Ann Goring; Jennifer King; Cameron J Grisdale; Natalie Grinshtein; Dolores Hambardzumyan; Karlyne M Reilly; Michael D Blough; J Gregory Cairncross; V Wee Yong; Marco A Marra; Steven J M Jones; David R Kaplan; Kathy D McCoy; Eric C Holland; Pinaki Bose; Jennifer A Chan; Stephen M Robbins; Donna L Senger Journal: Nat Commun Date: 2020-10-05 Impact factor: 14.919